Company Analysis The United Laboratories International Holdings Limited
1. Summary
Advantages
- Dividends (5.08%) are higher than the sector average (2.97%).
- The stock's return over the last year (55.15%) is higher than the sector average (48.55%).
- Current debt level 12.36% is below 100% and has decreased over 5 years from 31.82%.
- The company's current efficiency (ROE=18.14%) is higher than the sector average (ROE=-5.11%)
Disadvantages
- Price (17.78 HK$) is higher than fair price (15.79 HK$)
Similar companies
2. Share price and performance
2.1. Share price
2.3. Market efficiency
The United Laboratories International Holdings Limited | Healthcare | Index | |
---|---|---|---|
7 days | 15.9% | 7.6% | 1.4% |
90 days | 16.7% | 27.4% | 6.8% |
1 year | 55.1% | 48.6% | 45.7% |
3933 vs Sector: The United Laboratories International Holdings Limited has outperformed the "Healthcare" sector by 6.6% over the past year.
3933 vs Market: The United Laboratories International Holdings Limited has outperformed the market by 9.44% over the past year.
Stable price: 3933 is not significantly more volatile than the rest of the market on "Hong Kong Exchanges" over the last 3 months, with typical variations of +/- 5% per week.
Long period: 3933 with weekly volatility of 1.06% over the past year.
3. Summary of the report
4. Fundamental Analysis
4.1. Stock price and price forecast
Above fair price: The current price (17.78 HK$) is higher than the fair price (15.79 HK$).
Price is higher than fair: The current price (17.78 HK$) is 11.2% higher than the fair price.
4.2. P/E
P/E vs Sector: The company's P/E (8.4) is higher than that of the sector as a whole (-27.77).
P/E vs Market: The company's P/E (8.4) is lower than that of the market as a whole (36.81).
4.2.1 P/E Similar companies
4.3. P/BV
P/BV vs Sector: The company's P/BV (1.46) is lower than that of the sector as a whole (3.06).
P/BV vs Market: The company's P/BV (1.46) is lower than that of the market as a whole (2.39).
4.3.1 P/BV Similar companies
4.4. P/S
P/S vs Sector: The company's P/S indicator (1.62) is lower than that of the sector as a whole (54.94).
P/S vs Market: The company's P/S indicator (1.62) is lower than that of the market as a whole (19.31).
4.4.1 P/S Similar companies
4.5. EV/Ebitda
EV/Ebitda vs Sector: The company's EV/Ebitda (3.19) is lower than that of the sector as a whole (28.92).
EV/Ebitda vs Market: The company's EV/Ebitda (3.19) is lower than that of the market as a whole (37.9).
5. Profitability
5.1. Profitability and revenue
5.2. Earnings per share - EPS
5.3. Past profitability Net Income
Yield Trend: Rising and has grown by 49.99% over the last 5 years.
Earnings Slowdown: The last year's return (0.4082%) is below the 5-year average return (49.99%).
Profitability vs Sector: The return for the last year (0.4082%) is lower than the return for the sector (2.95%).
5.4. ROE
ROE vs Sector: The company's ROE (18.14%) is higher than that of the sector as a whole (-5.11%).
ROE vs Market: The company's ROE (18.14%) is higher than that of the market as a whole (-4.16%).
5.5. ROA
ROA vs Sector: The company's ROA (10.51%) is higher than that of the sector as a whole (0.2788%).
ROA vs Market: The company's ROA (10.51%) is higher than that of the market as a whole (2.86%).
5.6. ROIC
ROIC vs Sector: The company's ROIC (0%) is lower than that of the sector as a whole (0%).
ROIC vs Market: The company's ROIC (0%) is lower than that of the market as a whole (15.19%).
7. Dividends
7.1. Dividend yield vs Market
High yield: The dividend yield of the company 5.08% is higher than the average for the sector '2.97%.
7.2. Stability and increase in payments
Dividend stability: The company's dividend yield 5.08% has been steadily paid over the past 7 years, DSI=0.93.
Dividend growth: Company's dividend yield 5.08% has been growing over the last 5 years. Growth over 6 years.
7.3. Payout percentage
Dividend Coverage: Current payments from income (38.26%) are at a comfortable level.
Pay for your subscription
More functionality and data for company and portfolio analysis is available by subscription